- Home
- PSTV vs KXIN Comparison
PSTV vs KXIN Comparison
Compare PSTV & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- KXIN
- Stock Information
- Founded
- PSTV 1996
- KXIN 2015
- Country
- PSTV United States
- KXIN China
- Employees
- PSTV N/A
- KXIN N/A
- Industry
- PSTV Medical/Dental Instruments
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- PSTV Health Care
- KXIN Consumer Discretionary
- Exchange
- PSTV Nasdaq
- KXIN Nasdaq
- Market Cap
- PSTV 9.4M
- KXIN 10.5M
- IPO Year
- PSTV N/A
- KXIN N/A
- Fundamental
- Price
- PSTV $1.41
- KXIN $0.16
- Analyst Decision
- PSTV Strong Buy
- KXIN
- Analyst Count
- PSTV 2
- KXIN 0
- Target Price
- PSTV $14.00
- KXIN N/A
- AVG Volume (30 Days)
- PSTV 84.6K
- KXIN 90.2M
- Earning Date
- PSTV 10-29-2024
- KXIN 01-01-0001
- Dividend Yield
- PSTV N/A
- KXIN N/A
- EPS Growth
- PSTV N/A
- KXIN N/A
- EPS
- PSTV N/A
- KXIN N/A
- Revenue
- PSTV $5,509,000.00
- KXIN $12,679,000.00
- Revenue This Year
- PSTV $11.13
- KXIN N/A
- Revenue Next Year
- PSTV N/A
- KXIN N/A
- P/E Ratio
- PSTV N/A
- KXIN N/A
- Revenue Growth
- PSTV 113.20
- KXIN N/A
- 52 Week Low
- PSTV $0.97
- KXIN $0.06
- 52 Week High
- PSTV $2.78
- KXIN $3.55
- Technical
- Relative Strength Index (RSI)
- PSTV 46.79
- KXIN 49.05
- Support Level
- PSTV $1.20
- KXIN $0.16
- Resistance Level
- PSTV $1.45
- KXIN $0.19
- Average True Range (ATR)
- PSTV 0.10
- KXIN 0.07
- MACD
- PSTV 0.01
- KXIN -0.01
- Stochastic Oscillator
- PSTV 57.37
- KXIN 4.65
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.